Brief: Quantum Genomics announces 50 pct enrolment in QGC001 phase IIa trial

Quantum Genomics SA

08/09/2015 17:05

Sept 8 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Has recruited to date, more than half of patients in its 
phase IIa study for its drug candidate QGC001 
 
     
Source text for Eikon:  ID:nACT41181  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))